Hepatitis C

A clinical update

Research output: Contribution to journalReview article

17 Citations (Scopus)

Abstract

Hepatitis C virus is now known to be the causative agent for at least 90% of non-A, non-B hepatitis cases. In the few years since its characterization, much has been learned about this virus and the scope of its disease. It now appears that close to 100% of infections may become chronic, with delayed but potentially devastating consequences. The treatment options for hepatitis C remain limited and less than satisfactory. A vaccine seems to be a distant goal, but other strategies for treatment may be closer. For now, the best option remains prevention.

Original languageEnglish (US)
Pages (from-to)18-23
Number of pages6
JournalArchives of Surgery
Volume131
Issue number1
StatePublished - Jan 1 1996

Fingerprint

Hepatitis C
Hepacivirus
Hepatitis
Vaccines
Viruses
Infection

ASJC Scopus subject areas

  • Surgery

Cite this

Hepatitis C : A clinical update. / Colquhoun, Steven D.

In: Archives of Surgery, Vol. 131, No. 1, 01.01.1996, p. 18-23.

Research output: Contribution to journalReview article

Colquhoun, Steven D. / Hepatitis C : A clinical update. In: Archives of Surgery. 1996 ; Vol. 131, No. 1. pp. 18-23.
@article{235e299f667943ae844413390b51c150,
title = "Hepatitis C: A clinical update",
abstract = "Hepatitis C virus is now known to be the causative agent for at least 90{\%} of non-A, non-B hepatitis cases. In the few years since its characterization, much has been learned about this virus and the scope of its disease. It now appears that close to 100{\%} of infections may become chronic, with delayed but potentially devastating consequences. The treatment options for hepatitis C remain limited and less than satisfactory. A vaccine seems to be a distant goal, but other strategies for treatment may be closer. For now, the best option remains prevention.",
author = "Colquhoun, {Steven D}",
year = "1996",
month = "1",
day = "1",
language = "English (US)",
volume = "131",
pages = "18--23",
journal = "JAMA Surgery",
issn = "2168-6254",
publisher = "American Medical Association",
number = "1",

}

TY - JOUR

T1 - Hepatitis C

T2 - A clinical update

AU - Colquhoun, Steven D

PY - 1996/1/1

Y1 - 1996/1/1

N2 - Hepatitis C virus is now known to be the causative agent for at least 90% of non-A, non-B hepatitis cases. In the few years since its characterization, much has been learned about this virus and the scope of its disease. It now appears that close to 100% of infections may become chronic, with delayed but potentially devastating consequences. The treatment options for hepatitis C remain limited and less than satisfactory. A vaccine seems to be a distant goal, but other strategies for treatment may be closer. For now, the best option remains prevention.

AB - Hepatitis C virus is now known to be the causative agent for at least 90% of non-A, non-B hepatitis cases. In the few years since its characterization, much has been learned about this virus and the scope of its disease. It now appears that close to 100% of infections may become chronic, with delayed but potentially devastating consequences. The treatment options for hepatitis C remain limited and less than satisfactory. A vaccine seems to be a distant goal, but other strategies for treatment may be closer. For now, the best option remains prevention.

UR - http://www.scopus.com/inward/record.url?scp=0030060114&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030060114&partnerID=8YFLogxK

M3 - Review article

VL - 131

SP - 18

EP - 23

JO - JAMA Surgery

JF - JAMA Surgery

SN - 2168-6254

IS - 1

ER -